SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2025-06-19 08:22
Tx date 2025-06-18
$HLS
HLS Therapeutics Inc.
Edinboro, Dawn
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$495.00
+100 vol
$4.95 each
700
Filed 2025-06-19 08:21
Tx date 2025-06-18
$HLS
HLS Therapeutics Inc.
Edinboro, Dawn
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,982
+600 vol
$4.97 each
600
Filed 2025-06-19 08:21
Tx date 2022-06-17
$HLS
HLS Therapeutics Inc.
Edinboro, Dawn
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2025-03-19 12:21
Tx date 2025-03-17
$HLS
HLS Therapeutics Inc.
Edinboro, Dawn
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$60,150
+15,000 vol
$4.01 each
69,390
Filed 2024-05-15 11:33
Tx date 2024-05-13
$HLS
HLS Therapeutics Inc.
Edinboro, Dawn
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$59,100
+15,000 vol
$3.94 each
54,390
Filed 2023-08-23 13:00
Tx date 2023-08-22
$HLS
HLS Therapeutics Inc.
Edinboro, Dawn
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$94,000
+20,000 vol
$4.70 each
39,390
Filed 2022-12-16 09:38
Tx date 2022-06-17
$HLS
HLS Therapeutics Inc.
Edinboro, Dawn
5 - Senior Officer of Issuer
Direct Ownership
Performance Share Units
00 - Opening Balance-Initial SEDI Report
1,583
Filed 2022-12-15 15:25
Tx date 2022-06-17
$HLS
HLS Therapeutics Inc.
Edinboro, Dawn
5 - Senior Officer of Issuer
Direct Ownership
Performance Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2022-12-15 15:26
Tx date 2022-12-12
$HLS
HLS Therapeutics Inc.
Edinboro, Dawn
5 - Senior Officer of Issuer
Direct Ownership
Performance Share Units
56 - Grant of rights
$31,670
+3,167 vol
$10.00 each
7,250
Filed 2022-12-15 15:25
Tx date 2022-06-17
$HLS
HLS Therapeutics Inc.
Edinboro, Dawn
5 - Senior Officer of Issuer
Direct Ownership
Performance Share Units
00 - Opening Balance-Initial SEDI Report
4,083
Filed 2022-12-15 15:20
Tx date 2022-12-12
$HLS
HLS Therapeutics Inc.
Edinboro, Dawn
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$68,019
+6,423 vol
$10.59 each
19,390
Filed 2022-06-22 11:51
Tx date 2022-06-17
$HLS
HLS Therapeutics Inc.
Edinboro, Dawn
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
12,967